Drägerwerk AG & Co. KGaA

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, ABL.DE has a market cap of 207.88B. Regarding current trading prices, DRW8.DE is priced at $51.40, while ABL.DE trades at $119.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas ABL.DE's P/E ratio is 17.57. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to ABL.DE's ROE of +0.31%. Regarding short-term risk, DRW8.DE is more volatile compared to ABL.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, BSX.F has a market cap of 135.22B. Regarding current trading prices, DRW8.DE is priced at $51.40, while BSX.F trades at $91.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas BSX.F's P/E ratio is 75.54. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to BSX.F's ROE of +0.10%. Regarding short-term risk, DRW8.DE is more volatile compared to BSX.F. This indicates potentially higher risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, 2M6.DE has a market cap of 95.93B. Regarding current trading prices, DRW8.DE is priced at $51.40, while 2M6.DE trades at $74.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas 2M6.DE's P/E ratio is 25.88. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to 2M6.DE's ROE of +0.09%. Regarding short-term risk, DRW8.DE is more volatile compared to 2M6.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, SYK.DE has a market cap of 79.67B. Regarding current trading prices, DRW8.DE is priced at $51.40, while SYK.DE trades at $210.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas SYK.DE's P/E ratio is 38.50. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to SYK.DE's ROE of +0.15%. Regarding short-term risk, DRW8.DE is more volatile compared to SYK.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, PHI1.DE has a market cap of 20.12B. Regarding current trading prices, DRW8.DE is priced at $51.40, while PHI1.DE trades at $21.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas PHI1.DE's P/E ratio is 83.65. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to PHI1.DE's ROE of -0.06%. Regarding short-term risk, DRW8.DE is more volatile compared to PHI1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, EUZ.DE has a market cap of 1.24B. Regarding current trading prices, DRW8.DE is priced at $51.40, while EUZ.DE trades at $59.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas EUZ.DE's P/E ratio is 31.05. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to EUZ.DE's ROE of +0.14%. Regarding short-term risk, DRW8.DE is more volatile compared to EUZ.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, DRW3.DE has a market cap of 1.04B. Regarding current trading prices, DRW8.DE is priced at $51.40, while DRW3.DE trades at $62.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas DRW3.DE's P/E ratio is 9.38. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to DRW3.DE's ROE of +0.09%. Regarding short-term risk, DRW8.DE is more volatile compared to DRW3.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, SBS.DE has a market cap of 295.39M. Regarding current trading prices, DRW8.DE is priced at $51.40, while SBS.DE trades at $24.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas SBS.DE's P/E ratio is 29.63. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to SBS.DE's ROE of +0.04%. Regarding short-term risk, DRW8.DE is less volatile compared to SBS.DE. This indicates potentially lower risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, 6L9.F has a market cap of 207.23M. Regarding current trading prices, DRW8.DE is priced at $51.40, while 6L9.F trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas 6L9.F's P/E ratio is -0.05. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to 6L9.F's ROE of -0.85%. Regarding short-term risk, DRW8.DE is less volatile compared to 6L9.F. This indicates potentially lower risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, GME.DE has a market cap of 17.81M. Regarding current trading prices, DRW8.DE is priced at $51.40, while GME.DE trades at $3.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas GME.DE's P/E ratio is -18.28. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to GME.DE's ROE of +0.05%. Regarding short-term risk, DRW8.DE is less volatile compared to GME.DE. This indicates potentially lower risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, AAQ1.DE has a market cap of 17.66M. Regarding current trading prices, DRW8.DE is priced at $51.40, while AAQ1.DE trades at $1.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas AAQ1.DE's P/E ratio is -2.59. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to AAQ1.DE's ROE of -0.43%. Regarding short-term risk, DRW8.DE is more volatile compared to AAQ1.DE. This indicates potentially higher risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, E8X.DE has a market cap of 1.86M. Regarding current trading prices, DRW8.DE is priced at $51.40, while E8X.DE trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas E8X.DE's P/E ratio is -5.57. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to E8X.DE's ROE of +0.21%. Regarding short-term risk, DRW8.DE is less volatile compared to E8X.DE. This indicates potentially lower risk in terms of short-term price fluctuations for DRW8.DE.

DRW8.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, DRW8.DE stands at 1.05B. In comparison, SHL.DE comparison data is unavailable. Regarding current trading prices, DRW8.DE is priced at $51.40, while SHL.DE trades at N/A.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

DRW8.DE currently has a P/E ratio of 7.78, whereas SHL.DE's P/E ratio is N/A. In terms of profitability, DRW8.DE's ROE is +0.09%, compared to SHL.DE's ROE of +0.11%. Regarding short-term risk, Volatility data is not available for a full comparison. DRW8.DE has daily volatility of 1.95 and SHL.DE has daily volatility of N/A.